ArticleGynecologic oncology2021

Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.

Vijayalaxmi G Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.